N-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide

C19H22F3N7O2 — CID 78870345

IUPACN-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide
SMILESCc1cc(N2CCN(CC(=O)N(Cc3ccco3)CC(F)(F)F)CC2)n2ncnc2n1
InChIInChI=1S/C19H22F3N7O2/c1-14-9-16(29-18(25-14)23-13-24-29)27-6-4-26(5-7-27)11-17(30)28(12-19(20,21)22)10-15-3-2-8-31-15/h2-3,8-9,13H,4-7,10-12H2,1H3
InChIKeyBNQMHTAXLZMZRZ-UHFFFAOYSA-N
MW437.43 g/mol
LogP1.74
Rot. Bonds6

About N-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide

N-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide (PubChem CID 78870345) has the molecular formula C19H22F3N7O2 and a molecular weight of 437.43 g/mol. Its IUPAC name is N-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide.

Molecular Properties

Compound NameN-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide
PubChem CID78870345
Molecular FormulaC19H22F3N7O2
Molecular Weight437.43 g/mol
Exact Mass437.18
IUPAC NameN-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide
SMILESCc1cc(N2CCN(CC(=O)N(Cc3ccco3)CC(F)(F)F)CC2)n2ncnc2n1
InChIInChI=1S/C19H22F3N7O2/c1-14-9-16(29-18(25-14)23-13-24-29)27-6-4-26(5-7-27)11-17(30)28(12-19(20,21)22)10-15-3-2-8-31-15/h2-3,8-9,13H,4-7,10-12H2,1H3
InChIKeyBNQMHTAXLZMZRZ-UHFFFAOYSA-N
XLogP1.74
TPSA83.01 Ų
H-Bond Donors
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms31
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500437.43
LogP ≤ 51.74
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 108

Analyze N-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide?
The IUPAC name of N-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide (CID 78870345) is N-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide.
What is the SMILES notation for N-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide?
The canonical SMILES for N-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide is Cc1cc(N2CCN(CC(=O)N(Cc3ccco3)CC(F)(F)F)CC2)n2ncnc2n1.
What is the InChIKey of N-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide?
The InChIKey is BNQMHTAXLZMZRZ-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H22F3N7O2/c1-14-9-16(29-18(25-14)23-13-24-29)27-6-4-26(5-7-27)11-17(30)28(12-19(20,21)22)10-15-3-2-8-31-15/h2-3,8-9,13H,4-7,10-12H2,1H3.
What are the key properties of N-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide?
N-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide has a molecular weight of 437.43 g/mol, XLogP of 1.74, 6 rotatable bonds, 0 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-(furan-2-ylmethyl)-2-[4-(5-methyl-[1,2,4]triazolo[1,5-a]pyrimidin-7-yl)piperazin-1-yl]-N-(2,2,2-trifluoroethyl)acetamide is sourced from PubChem (CID 78870345), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).